Article · Volume 18, Issue 3 · pp. 315–320
Assessment of Drug Related Problems and Prescription Auditing in Patients Undergoing Chemotherapy for Breast Cancer in a Private Cancer Hospital: An Observational Study
Akash H Nataraj1, Soumya Shivalingappa Morabad1, Mallappa Hanumanthappa Shalavadi2, Chandrashekar V Mangannavar1, Irappa Vithoba Madhabhavi3
- 1Department of Pharmacy Practice, B.V.V.S Hanagal Shri Kumareshwar College of Pharmacy, Bagalkot, Karnataka, INDIA..
- 2Department of Pharmacology, B.V.V.S Hanagal Shri Kumareshwar College of Pharmacy, Bagalkot, Karnataka, INDIA..
- 3Department of Medical and Pediatric Oncology and Hematology, Kerudi Cancer Hospital, Bagalkot, Karnataka, INDIA..
Abstract
Background: Chemotherapy stands as a cornerstone in the management of breast cancer, offering substantial benefits in terms of disease control and survival outcomes. However, the complexity of chemotherapy regimens coupled with the potential for Drug-Related Problems (DRPs) underscores the importance of meticulous prescription auditing and proactive intervention to optimize treatment efficacy and safety.Aim and Objectives: Prescription auditing for patients receiving chemotherapy for breast cancer, determining the risk factors linked to breast cancer, and finding drug-related issues with chemotherapy treatments for patients with breast cancer.Materials and Methods: This is prospective observational research that lasted six months. Breast cancer patients who were above 18 years of age and were on chemotherapy along with supportive care medications were enrolled.Results: The study included 100 participants in total. The majority were in the age group of 40-60 years (n=72, 72%). Age is one of the most common risk factors in our study. Prescription auditing revealed that in (n=33, 33%) prescriptions, necessary pre-laboratory tests were not performed, and in (n=2, 2%) of patients, demographic details and dose calculation were missing during a few cycles of chemotherapy. Most commonly reported ADRs were chemotherapy-induced alopecia (n=60, 37%) and chemotherapy-induced anaemia (n=26, 16%). 61% ADRs were probable and 20% ADRs were certain according to the WHO-UMC causality assessment.Conclusion: This study underscores the importance of prescription auditing and careful monitoring of drug-related problems in breast cancer patients undergoing chemotherapy. Interventions based on these audits significantly enhance treatment safety and efficacy, potentially improving patient outcomes.
Keywords: Alopecia; Anaemia; Breast cancer; Causality assessment; Chemotherapy
The full text of this article is available as a PDF. Open the PDF.
